Live Quote · NASDAQMTSRHealthcare· Biotechnology

Metsera, Inc.

$70.50 0.35%($-0.25)
TickerSpark Score
52/100
Mixed
40
Valuation
20
Profitability
15
Growth
84
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MTSR research report →

52-Week Range81% of range
Low
$12.30
Current
$70.50
High
$83.86
Company Overviewmetsera.com

About the company

Metsera, Inc. operates as a clinical-stage biotechnology firm, specializing in crafting both injectable and oral nutrient-stimulated hormone analog peptides. These therapeutic compounds are primarily aimed at addressing obesity, overweight conditions, and associated health issues.

CEO
Christopher Whitten Bernard
IPO
2025
Employees
93
HQ
New York City, NY, US

Price Chart

+166.04% · this period
$83.18$48.13$13.08Jan 31Jun 26Nov 14
Valuation
Market Cap
$7.43B
P/E
-28.09
P/S
0.00
P/B
21.96
EV/EBITDA
-26.72
Div Yield
0.00%
Profitability
Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
-60.74%
ROIC
-59.10%
Growth & Income
Revenue
$0 · 0.00%
Net Income
$-209,127,000 · -343.01%
EPS
$-2.03 · -113.68%
Op Income
$-224,833,000
FCF YoY
-181.83%
Performance & Tape
52W High
$83.86
52W Low
$12.30
50D MA
$53.47
200D MA
$35.09
Beta
1.70
Avg Volume
3.50M

Get TickerSpark's AI analysis on MTSR

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Nov 13, 25FMR LLCother2,230,450
Nov 13, 25ARCH Venture Partners XII, LLCsell8,313,680
Nov 13, 25Marso Stevenother17,000
Nov 13, 25Marso Stevensell17,000
Nov 13, 25Marso Stevensell21,279
Nov 13, 25Marso Stevensell120,000
Nov 13, 25BERNS PAUL Lother4,031
Nov 13, 25BERNS PAUL Lsell24,188
Nov 13, 25BERNS PAUL Lsell223,430
Nov 13, 25BERNS PAUL Lsell957,559
Coverage · MTSR

Our MTSR coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on MTSR yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate MTSR report →
Internal Compare

Similar companies

Peers in the same neighborhood.